-0.88%
7.62%
3.67%
18.53%
40.08%
54.09%
158.78%
AI Spotlight on CBAV
Company Description
Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics.The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders.Its clinics offers myopia, hyperopia, astigmatism, presbyopia, cataract, retina, pediatric ophthalmology, glaucoma, squint, cornea, neuroftalmología, vías lagrimales, and oculoplasty treatments.
It operates approximately 90 centers in Spain, Germany, Austria, and Italy.The company is based in Madrid, Spain.
Market Data
| Last Price | 33.9 |
| Change Percentage | -0.88% |
| Open | 33.9 |
| Previous Close | 34.2 |
| Market Cap ( Millions) | 553 |
| Volume | 1052 |
| Year High | 39.5 |
| Year Low | 23.3 |
| M A 50 | 32.8 |
| M A 200 | 31.58 |
Financial Ratios
| FCF Yield | 6.58% |
| Dividend Yield | 4.63% |
| ROE | 41.55% |
| Debt / Equity | 73.41% |
| Net Debt / EBIDTA | 41.06% |
| Price To Book | 6.86 |
| Price Earnings Ratio | 15.5 |
| Price To FCF | 15.2 |
| Price To sales | 2.2 |
| EV / EBITDA | 8.17 |
News
- Jan -29 - Top Dividend Stocks To Watch In January 2025
- Jan -03 - Discovering 3 Undiscovered Gems with Promising Potential
- Dec -19 - Dividend Stocks To Consider In December 2024
- Nov -15 - Undiscovered Gems With Strong Fundamentals For November 2024
- Nov -11 - Top Dividend Stocks To Consider For Your Portfolio
- Oct -18 - Clínica Baviera And 2 Other High-Quality Dividend Stocks
- Sep -19 - 3 Dividend Stocks To Consider With Up To 9.8% Yield
Business Breakdown
Expected Mid-Term Growth
Segment n°1 -> Interventions
Expected Growth : 8 %
What the company do ?
Clínica Baviera's interventions involve personalized eye care treatments, including LASIK, cataract surgery, and glaucoma management, using advanced technology and expert medical professionals.
Why we expect these perspectives ?
Strong demand for ophthalmology services, increasing prevalence of eye disorders, strategic partnerships, and expansion into new markets drive Clínica Baviera's 8% growth. Additionally, investments in advanced medical technology, a skilled workforce, and effective cost management contribute to the company's success.
Segment n°2 -> Others
Expected Growth : 7 %
What the company do ?
Others from Clínica Baviera, S.A. refers to miscellaneous services or products offered by the clinic beyond their primary medical services.
Why we expect these perspectives ?
Strong brand reputation, strategic partnerships, and expansion into new markets drive Clínica Baviera's growth. Additionally, investments in digital transformation, process efficiency, and talent acquisition contribute to its success. Furthermore, the increasing demand for ophthalmology services, particularly in Spain and Portugal, also fuels the company's growth.
Segment n°3 -> Consultations
Expected Growth : 10 %
What the company do ?
Consultations from Clínica Baviera, S.A. provide expert medical advice and personalized care for patients, offering comprehensive health solutions.
Why we expect these perspectives ?
Strong demand for ophthalmology services, increasing awareness of eye health, and strategic partnerships with healthcare providers drive Consultations from Clínica Baviera, S.A.'s 10% growth. Additionally, investments in digital platforms and expansion into new markets contribute to the company's upward trend.
Clínica Baviera, S.A. Products
| Product Range | What is it ? |
|---|---|
| ReLEx Smile | A minimally invasive refractive surgery procedure that combines the benefits of LASIK and PRK, providing high precision and accuracy in vision correction. |
| Femtosecond Laser Technology | A state-of-the-art technology used in refractive surgery, enabling precise and safe procedures with minimal recovery time. |
| Implantable Lenses | Artificial lenses implanted inside the eye to correct vision problems, providing a permanent solution for presbyopia, myopia, and hyperopia. |
| Cataract Surgery | A surgical procedure to remove the cloudy natural lens (cataract) and replace it with an artificial lens, restoring clear vision. |
| Refractive Lens Exchange | A surgical procedure that replaces the natural lens with an artificial lens, correcting vision problems such as presbyopia and high prescriptions. |
| Corneal Cross-Linking | A minimally invasive procedure to strengthen the cornea, treating keratoconus and other corneal disorders. |
Clínica Baviera, S.A.'s Porter Forces
Threat Of Substitutes
The threat of substitutes is low for Clínica Baviera, S.A. because the company provides specialized eye care services that are not easily substitutable.
Bargaining Power Of Customers
The bargaining power of customers is medium for Clínica Baviera, S.A. because while customers have some flexibility to choose from different eye care providers, the company's reputation and quality of service limit their bargaining power.
Bargaining Power Of Suppliers
The bargaining power of suppliers is low for Clínica Baviera, S.A. because the company is a large buyer of medical equipment and supplies, giving it significant negotiating power.
Threat Of New Entrants
The threat of new entrants is high for Clínica Baviera, S.A. because the eye care industry is attractive and has relatively low barriers to entry, making it easier for new competitors to enter the market.
Intensity Of Rivalry
The intensity of rivalry is high for Clínica Baviera, S.A. because the eye care industry is highly competitive, with many established players competing for market share.
Capital Structure
| Value | |
|---|---|
| Debt Weight | 10.92% |
| Debt Cost | 3.95% |
| Equity Weight | 89.08% |
| Equity Cost | 7.00% |
| WACC | 6.66% |
| Leverage | 12.26% |
Clínica Baviera, S.A. : Quality Control
Clínica Baviera, S.A. passed 4 out of 9 key points:
Historical Valuation
Price/Earnings Ratio
Margin Valuation
Peers Valuation
Competitors
| Company | Rational |
|---|---|
| SNT.WA | Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. The company sells medical equipment used in diagnostics and therapy, and … |
| VOX.WA | Voxel S.A. operates a network of diagnostic imaging laboratories. Its diagnostic imaging services include magnetic resonance imaging scans, computed tomography scans, positron emission tomography, and single photon emission computed tomography. … |
| AMBEA.ST | Ambea AB (publ) provides housing, support, education, and personnel for health and social care for the elderly and people with disabilities in Sweden, Norway, and Denmark. The company operates through … |
| FAE.MC | Faes Farma, S.A., a pharmaceutical company, researches, develops, produces, and commercializes pharmaceutical products and raw materials in Spain and internationally. The company's product portfolio includes prescription drugs, generic drugs, over-the-counter … |
| SLV.WA | Selvita S.A. operates as a contract research organization in Poland, rest of Europe, the United States, and internationally. It operates in two segments, Contract Research Organization (CRO) services, and Bioinformatics. … |
Peers Metrics
DCF BETA
Expected Cash-Flows
Scoring Insights
Peers Group Analysis
🥇
Faes Farma
A-Score
1-Year Total Return ->
🥈
Clínica Baviera
A-Score
1-Year Total Return ->
🥉
Voxel
A-Score
1-Year Total Return ->
4
Synektik
A-Score
1-Year Total Return ->
5
Ambea
A-Score
1-Year Total Return ->
6
